Improving quality of health care is a global priority. Before quality benchmarks are established, we first must understand rates of adverse events (AEs). This project assessed risk-adjusted rates of inpatient AEs for soft tissue reconstructive procedures.
T he Institute of Medicine's reports on health care delivery 1,2 estimated approximately 200,000 patient deaths yearly attributable to system-related deficiencies. Although plastic reconstructive procedures generally have low mortality, the same system failures noted in the Institute of Medicine reports that result in complication and mortality also impact plastic surgical patients. Recent articles highlight the importance of risk-limiting techniques for modern plastic surgeons. 3, 4 To apply these techniques and improve plastic surgery care, we must first understand the current state of the field by measuring and monitoring rates of preventable adverse events (AEs).
Adverse events are defined as unintended injuries caused by medical care rather than underlying disease. Rates of AEs vary substantially between hospitals and surgery types. 5Y8 Adverse events are not rare; 3.7% of all hospital admissions experience an AE and most of these events are considered preventable. 9, 10 Beyond the impact on the patient and their family, AEs increase hospital resource use and associated costs. 11 Given the broad impact of AEs, there has been global prioritization of patient safety and associated hospital performance.
Plastic surgery is a unique field and likely has a different profile of AEs compared to other subspecialties. 7 ,12Y14 Before establishing quality benchmarks; we first must understand national rates of AEs. Risk-adjusted rates for individual surgical procedures provide information on which patients undergoing what procedures are at higher risk. Identifying these high-risk patients help guide future clinical studies focused on patient safety. Our specific aim was to assess riskadjusted rates of inpatient AEs for general reconstructive soft tissue procedures using established measures. Our secondary goal was to perform a detailed evaluation of these rates in a specific procedure, dermolipectomy, to highlight at-risk patient populations.
METHODS

Data Source
We extracted data from the 2005 to 2009 Nationwide Inpatient Sample (NIS) database, developed by the Agency for Healthcare Research and Quality's (AHRQ) Healthcare Cost and Utilization Project. The NIS contains hospital discharge records for more than 8 million hospital stays. Data are collected from more than 1000 different hospitals across the United States and represent approximately 20% of US community hospitals. Data from the NIS are weighted to represent all US hospital stays. 15 
Patient Safety Indicators
To identify AEs during an inpatient hospital stay, we used PSI. These measures use standardized methodology to identify possible AEs using hospital International Classification of Diseases, Ninth Revision (ICD-9) codes. The AHRQ created these measures by using input from literature review, clinicians, and coding specialists. These indicators are based on Medicare Severity Diagnosis Related Groups and International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes. 16 The AHRQ has developed software to identify PSIs and apply risk adjustments to each event, which include age, sex, age-sex interactions, diagnostic-related group, and comorbidities. 17 Each AE has a unique set of inclusion and exclusion criteria and riskadjustors. We used PSI software version 4.3 and all rates reported use the risk-adjustment provided by the AHRQ software. Only PSIs applicable to plastic surgeries were included (pressure ulcer, death among surgical inpatients with serious treatable conditions, postoperative hemorrhage or hematoma, postoperative respiratory failure, postoperative PE/DVT, and postoperative sepsis). As PSIs identify complications of care, by definition they are limited to secondary diagnoses, thus a patient admitted with a pressure ulcer as the principal diagnosis would not be considered at-risk for a pressure ulcer acquired in-hospital.
Study Sample
The study sample included adults who underwent soft tissue plastic surgery procedures that required an inpatient hospital stay. We focused upon soft tissue reconstructive procedures because these represent the core of plastic surgery and could be performed by any surgeon trained in plastic surgery. Patients were identified by ICD-9-CM procedure codes for soft tissue reconstructive operations. To be included in the cohort, the plastic surgery procedure code had to be identified as the principal procedure. Current Procedural Terminology codes were not available in this data set to identify procedures performed. We excluded patients with secondary reconstructive procedures, as the AEs identified may not be related to the soft tissue reconstruction, as in the following example: a trauma patient who had a f lap to cover a wound and also had a postoperative pulmonary embolism (PE). Our analysis would not be able to discriminate whether the PE was associated with the f lap reconstruction or a previous surgery within the same hospital stay the patient underwent for their trauma. Therefore, to minimize capture of AEs associated with nonplastic reconstructive surgical care, we included only patients whose primary/first procedure was soft tissue reconstruction.
Our plastic surgery cohort included patient records with the following primary procedures identified using ICD-9-CM codes: hand skin graft (86.61, 86.62, and 86.63); free skin graft not elsewhere classified (NEC) (86.69); pedicle graft/f lap (86.70, 86.71, 86.72, 86.74, and 86.75); size reduction (86.83); skin repair and plasty NEC (86.89); and breast reconstruction (85.7Â). To allow reconstructive patients to be compared to all other adult surgical patients, we established a comparison group using the 2009 NIS database that included all other surgical inpatients with elective admission.
We subanalyzed patients who underwent size reduction surgery (ICD-9, 86.83). With the increase of patients receiving bariatric surgery, there has been an increase in elective size reduction surgeries, such as dermolipectomy or liposuction. The patients in this cohort had an inpatient stay with a median length of stay (LOS) of 2 days, thus eliminating any who had elective office procedures. This population has high reported rates of AEs, such as hematoma rates from 5% to 50%. 18, 19 Therefore, we felt this subpopulation of elective procedures should undergo more in-depth analyses.
Procedure Indicators
To better understand the case-mix of patients undergoing the selected reconstructive procedures of interest, we identified common diagnoses for our patients. The diagnoses included burn patients (ICD-9-CM, 94Â), postoperative complications (ICD-9-CM, 998), osteomyelitis, periostitis, and other infections involving bone (ICD-9-CM, 730), and spinal cord injury patients (ICD-9-CM, 344.0, 344.1, 806, 907.2, and 952).
Surgeon Specialty
To understand whether these procedures were performed by a plastic or general surgeon, we used an approach previously defined to obtain surgeon information in the NIS database using de-identified physician identifiers. 20 A physician was classified as a ''plastic'' surgeon if s/he performed a breast reduction or breast reconstruction surgery during the same year s/he performed one of the identified procedures in our study. Likewise, if the surgeon performed an appendectomy s/he was classified as a ''general'' surgeon.
Statistical Analysis
As the NIS database is survey-based, all analyses accounted for the study design using weights, clusters, and stratum. Univariate 
RESULTS
A total of 409,991 patient records in the NIS database included a principal soft tissue reconstructive procedure between 2005 and 2010. Table 1 presents the breakdown of patients by different procedures. Free skin graft NEC was the most frequent procedure, representing 37.92% of all patients in the study followed by patients undergoing a pedicle graft or f lap (24.74%) and size reduction (20.64%). The least frequent operations were skin repair and plasty, NEC (1.83%). Overall, 16,635 (4.06%) patients developed an AE during their hospital stay. Patients receiving a pedicle graft or f lap had the highest percentage of AEs (5.08%). Breast reconstruction had the lowest percentage reported AEs (1.97%). To better understand the diagnosis necessitating the soft tissue reconstruction, we assessed the most common patient diagnoses coded during the patient's hospital stay ( Table 2 ). This showed a diverse set of diagnoses (spinal cord injury, burns, and postoperative complications) for the most common procedures skin graft and flaps. Table 3 displays demographics stratified by patients with and without any PSI during their hospital stay. Most of the patients receiving soft tissue reconstruction are between 40 and 64 years and patients with a PSI were more frequently older (P G 0.0001). Patient with a PSI were more likely to be male, nonwhite with Medicare or Medicaid (government insurance) (P G 0.05). Most patients had few noted comorbidities; of patients who had a PSI, 92.6% had no recorded comorbidity, compared to 96.2% of patients with no PSI (P G 0.0001).
Outcomes varied significantly between patients with and without a PSI. Risk-adjusted mortality rates for patients with a PSI were 7.5% compared to 0.6% for patients without a PSI (P G 0.0001). Average LOS (in days) was almost triple in patients with a PSI (27.1) compared to those without a PSI (9.6) (P G 0.0001). Correspondingly, total charges were significantly higher in patients with PSI compared to those without PSI ($195,700 vs $69,100, respectively) (P G 0.0001).
Hospital characteristics are shown in Table 4 . These examine the association of hospital characteristics. Patients with a PSI were more likely to be discharged from a teaching hospital in an urban area compared to patients without a PSI (P G 0.05). There were slight differences in the distribution of patients with PSIs compared to those without a PSI by regional area, with the Northeastern United States having the fewest patients with a PSI (17.0%, P = 0.0008).
Mixed effect models confirmed statistical significance from the univariate results for patient age (P G 0.0001), race (P G 0.0001), primary payer (P G 0.0001), and sex (P G 0.0001). The odds of developing a PSI during hospitalization were 18% higher in blacks compared to whites [odds ratio (OR), 1.179; 95% confidence interval (CI), 1.121Y1.241]. Both Medicare and Medicaid recipients had higher odds of developing a PSI compared to patients with private insurance (OR, 1.094; CI, 1.047Y1.142 and OR, 1.353; CI, 1.287Y1.423, respectively). The odds of developing a PSI were 44% greater in males compared to females (OR, 1.444; CI, 1.398Y1.491). Receiving an operation in a smaller nonteaching hospital showed decreased odds for developing a PSI (P G 0.0001). There were also regional variations. Compared to the western United States, patients in the south were 21% more likely to develop a PSI and 22% more likely in the Midwest (OR, 1.207; CI, 1.155Y1.126 and OR, 1.224; CI, 1.164Y1.288, respectively). Patients in the northeast had decreased odds of developing a PSI compared to patients in the west (OR, 0.852; CI, 0.808Y0.898).
Risk-adjusted PSI rates for our reconstructive cohort and all other surgical procedures cohort are compared in Figure 1 . Plastic surgery patients had significantly lower rates of most PSIs compared to all other surgical patients. The only 2 PSIs that had similar rates between the plastic surgery group and the other surgical groups were death among surgical inpatients with serious treatable conditions (128.26 vs 139.45, P = 0.848) and postoperative hemorrhage/ hematoma (P = 0.089). Plastic surgery had significantly lower PSI risk-adjusted rates for pressure ulcer (26.39 vs 36.11, P G 0.0001), PO pulmonary embolism or deep vein thrombosis (PE/DVT) (14.77 vs 18.01, P G 0.0001), and PO sepsis (17.84 vs 21.87, P G 0.0001). Data for PSI risk-adjusted rates per 1000 patients at risk for each individual procedure are available as a supplement.
We next separately analyzed the size reduction group. These 84,605 patients represented the third largest group. Size reduction procedures had significantly lower risk-adjusted PSI rates compared to all other surgical inpatients: pressure ulcer (13.68 vs 36.11, P G 0.0001), PO respiratory failure (7.09 vs 15.89, P G 0.0001), PO PE/DVT (5.99 vs 18.01, P G 0.0001), and PO sepsis (11.09 vs 21.87, P G0.0001). However, these patients had significantly higher rates of PO hemorrhage or hematoma (9.83 vs 5.59, P G 0.0001) compared to all surgical patients. Further investigation of the higher hematoma rates revealed that men had significantly higher rates compared to females (11.93 vs 2.74, P G 0.0001). Men with private payer had the highest risk-adjusted rate (14.89), followed by Medicaid (12.24), Medicare (9.50), and self-pay (7.81) (P G 0.0001) (Fig. 2 ).
DISCUSSION
Plastic surgery is a unique surgical discipline. There are essentially 2 groups of patients requiring reconstructive surgery: elective patients who are generally young, healthy adults and complex patients requiring reconstructive surgery due to other conditions, such as wound closure for exposed hardware, reconstruction after tumor extirpation, or injury repair such as burns. In our inpatient study population, we found overall reconstructive patients had lower risk-adjusted rates of PSIs than other surgical disciplines, but PSIs were not uncommon. During this 5-year period, a total of 16,635 patients experienced at least 1 potentially preventable AE during their hospital stay. These events led to more than 7% excess mortality, more than double a patient's LOS, and substantial associated hospital charges.
The first goal of our study was to describe the current rates of AEs for the field. Not surprisingly, we found that PSI risk-adjusted rate for plastic surgery patients were significantly lower than all other surgical patients with the exception of death among surgical inpatients with serious treatable complications (PSI04) and postoperative hemorrhage/hematoma (PSI09). The finding that the rate of PS104, also known as ''failure to rescue,'' was similar between the soft tissue group and all other surgical patients was surprising. Failure to rescue is an interesting variable that has received a large amount of attention in health quality research. 21 It represents death after surgery from a hospital acquired serious condition, such as DVT or pneumonia (ie, failure to prevent mortality after a complication has occurred). Some patients who require soft tissue reconstruction, such as burn patients, are at high risk for complications and mortality. Lower rates of failure to rescue seem to be related to hospital factors such as volume of surgery and high nurse to patient ratios. 22, 23 Thus, to improve PSIO4 rates in soft tissue reconstruction, a first step may be to focus on hospital factors in high-risk populations.
Pressure ulcers represent an important AE in the plastic surgery population. Plastic surgeons often care for pressure ulcers but the pressure ulcer diagnoses identified in this study were not the primary diagnosis but developed secondarily after a soft tissue reconstructive procedure: a hospital-acquired pressure sore developed in plastic surgical patients. Pressure ulcers are an important safety indicator as demonstrated by their ''never-event'' status established by Medicare 24 and understanding that this AE is part of maintaining US plastic surgery certification. 25 It is of value to highlight that this AE occurs in plastic surgery patients because once recognized as an area for improvement, plastic surgeons have the ability and knowledge to prevent this outcome.
Our final analyses looked deeply into a growing plastic surgery subgroup, size reduction patients. This subgroup consists of patients receiving body-contouring procedures commonly performed after significant weight loss. These elective surgeries have been increasing due to increased in bariatric procedures; it represents the third largest subgroup in this analysis. 26 We found that this group had high rates of hematoma, which is consistent with published rates in the literature. 27, 28 This finding of high rates of clinically significant hematomas is related to a topic that has been extensively discussed within the plastic surgery community: postoperative hematoma and the use of chemical DVT prophylaxis. 29 Plastic surgeons are concerned that chemical prophylaxis might increase the rate of hematomas and there is evidence that substantial disparities exist in the use of such treatment. 30 Indeed, many plastic surgeons do not follow the guidelines due to their concern about a high risk of hematoma beneath large undermined areas. 31, 32 These data suggest that plastic surgeons' concerns about hematoma are valid especially for men having size reduction surgery. Thus, this analysis helps direct next steps to improve quality of care by highlighting areas where further detailed studies can be focused. Clinically rich data are warranted to validate these increased rates of hematoma and analyze the causality of such events.
Similar to other studies, PSIs among plastic surgery patients were more frequently seen in blacks with public insurance, both Medicare and Medicaid treated in urban, teaching hospitals. 7, 33, 34 Even after adjustment for disease severity and known confounders, these factor were still associated with higher odds of PSI development. These data might ref lect delayed access to care, although further studies are needed in these different patient populations. The disparities shown in our data for these elective procedures highlight the need to establish tangible benchmarks. Our study is the first step at obtaining measurements of these rates in this unique surgical specialty.
Limitations
Our study has important limitations. Using administrative data, we are aware of miscoded events and incomplete risk adjustment due to ICD-9 coding limitations and completeness for secondary diagnoses. 14, 35 Also, these data have significant noise, certainly for hospitals in the lowest tertile of plastic surgery procedures. Therefore, we are only reporting data at the aggregate national level, with low-volume hospitals contributing to both the numerator and denominator of each event.
Another concern is the validity of identified AEs due to the lack of present on admission (POA) coding. 36, 37 Certain PSIs are greatly inf luenced by the inclusion of POA information and the validity of these rates is questionable in the absence of POA codes. 38Y40 Despite these limitations, PSIs are used for safety monitoring across the nation, and often considered an important first step in identifying clinical targets for more detailed clinical data exploration.
CONCLUSIONS
This study establishes current rates for AEs within specific plastic surgery procedures. As plastic surgery patients are relatively young and healthy, it is important to achieve quality improvements to prevent the long-term costs to society and the patient of these AEs. Because it is based on robust risk adjustment and stratification, this work can serve as a guideline for targeted quality improvement and used in the establishment of future quality benchmarks. Further prospective studies should be designed to elucidate the drivers of AEs in this population, as the results may be extrapolated and result in strategies to improve outcomes across many surgical disciplines.
